STAT Plus: Public speakers at FDA advisory meetings have financial conflicts, but do they sway outcomes?

About one-fifth of the conflicted speakers did not disclose financial ties to drug companies.

More From BioPortfolio on "STAT Plus: Public speakers at FDA advisory meetings have financial conflicts, but do they sway outcomes?"